Treatment of spasticity in children and adolescents with cerebral palsy in Northern Europe: a CP-North registry study

Treatment of spasticity in children and adolescents with cerebral palsy in Northern Europe: a CP-North registry study

Abstract Background Spasticity is present in more than 80% of the population with cerebral palsy (CP). The aim of this study was to describe and compare the use of three spasticity reducing methods; Botulinum toxin-A therapy (BTX-A), Selective dorsal rhizotomy (SDR) and Intrathecal baclofen therapy...

Full description

Bibliographic Details
Main Authors: Gunnar Hägglund, Sandra Julsen Hollung, Matti Ahonen, Guro L. Andersen, Guðbjörg Eggertsdóttir, Mark S. Gaston, Reidun Jahnsen, Ira Jeglinsky-Kankainen, Kirsten Nordbye-Nielsen, Ilaria Tresoldi, Ann I. Alriksson-Schmidt
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Neurology
Subjects:
Spasticity
Cerebral palsy
Treatment
Baclofen
Selective dorsal rhizotomy
Botulinum toxin
Online Access:https://doi.org/10.1186/s12883-021-02289-3

Internet

https://doi.org/10.1186/s12883-021-02289-3

Similar Items